Literature DB >> 17446835

Photodynamic therapy for pancreatic cancer.

Bo-Guang Fan1, Ake Andrén-Sandberg.   

Abstract

OBJECTIVES: This study examined the status of photodynamic therapy (PDT) in the treatment of cancers of the pancreas.
METHODS: Original and review articles, editorials, and case reports published primarily in English and listed in Medline/ISI up to October 2006 or identified by a manual search have been reviewed in an attempt to provide a comprehensive overview of the mechanisms of PDT action and clinical application of PDT in the treatment of pancreatic cancers.
RESULTS: Photodynamic therapy represents a novel treatment of pancreatic malignancy; it produces local necrosis of tissue with light after administration of a photosensitizing agent. Evidences from in vivo and in vitro results have shown that PDT significantly decreases pancreatic cancer cell growth, destroys pancreatic carcinoma, and prolongs the survival of patients with unresectable pancreatic malignancy, and also show that PDT has disadvantages and limitations for the treatment of pancreatic cancer.
CONCLUSIONS: Photodynamic therapy can be an effective treatment of patients with pancreatic cancer, but more extensive preclinical and clinical trials are needed for further improvement in the clinical application of PDT, especially in avoidance of complications during PDT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446835     DOI: 10.1097/mpa.0b013e3180439c50

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  22 in total

1.  Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.

Authors:  Michael J Rose; Pradip K Mascharak
Journal:  Coord Chem Rev       Date:  2008-10-01       Impact factor: 22.315

2.  Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.

Authors:  Luo-Wei Wang; Zheng Huang; Han Lin; Zhao-Shen Li; Fred Hetzel; Bolin Liu Md
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-01-30       Impact factor: 3.631

3.  Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.

Authors:  Adnan O Abu-Yousif; Anne C E Moor; Xiang Zheng; Mark D Savellano; Weiping Yu; Pål K Selbo; Tayyaba Hasan
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

4.  Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.

Authors:  Shifalika Tangutoori; Bryan Q Spring; Zhiming Mai; Akilan Palanisami; Lawrence B Mensah; Tayyaba Hasan
Journal:  Nanomedicine       Date:  2015-09-25       Impact factor: 5.307

5.  Characterization of the role of the photosensitizer, deuteporfin, in the detection of lymphatic metastases in a pancreatic cancer xenograft model.

Authors:  Xinzhe Yu; Hengchao Li; Deliang Fu; Chen Jin; J I Li
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

6.  Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell.

Authors:  Min Zhou; Qian-Wen Ni; Shan-Ying Yang; Chun-Ying Qu; Peng-Cheng Zhao; Jian-Cheng Zhang; Lei-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

7.  Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

Authors:  Kimberley S Samkoe; Alina Chen; Imran Rizvi; Julia A O'Hara; P Jack Hoopes; Stephen P Pereira; Tayyaba Hasan; Brian W Pogue
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

8.  Pancreatic cancer-associated Cathepsin E as a drug activator.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Huamin Wang; Craig D Logsdon; Ching-Hsuan Tung
Journal:  J Control Release       Date:  2013-02-26       Impact factor: 9.776

9.  Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer.

Authors:  Shinichi Ota; Jean-Francois H Geschwind; Manon Buijs; Joost W Wijlemans; Byung Kook Kwak; Shanmugasundaram Ganapathy-Kanniappan
Journal:  Target Oncol       Date:  2013-03-26       Impact factor: 4.493

10.  Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo.

Authors:  Qi Xie; Lin Jia; Yan-Hong Liu; Cheng-Gang Wei
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.